✦ LIBER ✦

PMS37 A MICROSIMULATION-BASED COST-UTILITY ANALYSIS OF RITUXIMAB (MABTHERA ®) IN PATIENTS WITH RHEUMATIC ARTHRITIS IN SPAIN

✍ Scribed by I Fernández; C Varela; X Badia; Á Carreño; C Polanco

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PAR8 USING MABTHERA IN PATIENTS WITH RHE

✍ A Kielhorn; C Alvarez; M Aristides; A Diamantopoulos 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PAR6 COST-UTILITY ANALYSIS OF RITUXIMAB

✍ B Mistry; J McCormick; A Diamantopoulos; A Kielhorn 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PCN69 Cost-Effectiveness Analysis of Mai

✍ F. Demousis; A. Athanasiadis 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Cost-utility analysis of treatment strat

✍ Van den Hout, Wilbert B. ;Goekoop-Ruiterman, Yvonne P. M. ;Allaart, Cornelia F. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 2 views

UK cost-utility analysis of rituximab in

✍ Kielhorn, Adrian; Porter, Duncan; Diamantopoulos, Alexander; Lewis, Gavin 📂 Article 📅 2008 🏛 Informa plc 🌐 English ⚖ 147 KB

PMS39 Cost-Effectiveness Analysis of Cer

✍ T. Piha; E.D.S. Meirelles; W. Kuriki; P.A. Miranda 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB